Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: ChemMedChem. 2014 Apr 1;9(8):1677–1682. doi: 10.1002/cmdc.201402051

Figure 2.

Figure 2

Structure and pharmacological profile of HTS hit 7 (VU0480131). A) Structure and pharmacology of 7 as an HTS stock solution (hM5 IC50 = 9.3 μM) and as resynthesized, fresh powder (hM5 IC50 = 1.12 μM). B) Concentration-response curves (CRCs) of 7 for human and rat M5, as well as human M1-M4 (IC50s >30 μM, n=3). C) [3H]NMS competition binding [n = 3] in membranes prepped from human M5 cells, showing competitive displacement (Ki = 1.3 μM).